← Leaderboards
Eric M Pietras
University Of California, San Francisco
$4,768,442
Attributed
$5,392,784
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,392,784 · 6
By mechanism
R01$4,550,501 · 3
K01$690,958 · 1
R56$99,999 · 1
F32$51,326 · 1
Top collaborators
- Brett M Stevens3 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Emmanuelle Passegue$22,475,888
- Priscilla Y. Hsue$28,957,856
- Bradley Wayne Blaser$2,492,752
- Adam Wayne Carrico$20,345,043
- Qing Li$7,606,806
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoHematopoietic Stem CellsMyelogenousCellsSignal TransductionInflammatoryHomeostasisHematopoieticCytokineMolecularMyeloproliferative DiseaseChronicHematologic NeoplasmsTissuesProductionInflammationHematopoiesisInvestigationBone MarrowMortalityFitnessExposure ToExperimental StudyEvolution
Grant awards (21)
Aberrant glycolysis as a driver of mutant HSPC expansion in clonal hematopoiesis$435,966
R01 · FY2025 · DK · contact PI
Metabolic targeting of heterogenous myelodysplastic syndrome stem cells$423,743
R01 · FY2025 · CA · contact PI
Aberrant glycolysis as a driver of mutant HSPC expansion in clonal hematopoiesis$425,335
R01 · FY2024 · DK · contact PI
Metabolic targeting of heterogenous myelodysplastic syndrome stem cells$402,556
R01 · FY2024 · CA · contact PI
Aberrant glycolysis as a driver of mutant HSPC expansion in clonal hematopoiesis$456,912
R01 · FY2023 · DK · contact PI
Metabolic targeting of heterogenous myelodysplastic syndrome stem cells$422,385
R01 · FY2023 · CA · contact PI
Impact of IL-1 signaling on hematopoietic stem cell function and emergence of clonal hematopoiesis.$378,798
R01 · FY2023 · DK · contact PI
Impact of IL-1 signaling on hematopoietic stem cell function and emergence of clonal hematopoiesis.$378,798
R01 · FY2022 · DK · contact PI
Impact of IL-1 signaling on hematopoietic stem cell function and emergence of clonal hematopoiesis.$51,209
R01 · FY2022 · DK · contact PI
Impact of IL-1 signaling on hematopoietic stem cell function and emergence of clonal hematopoiesis.$378,798
R01 · FY2021 · DK · contact PI
Crosstalk between aberrant glycolysis and inflammation in clonal hematopoiesis.$99,999
R56 · FY2021 · DK · contact PI
Impact of IL-1 signaling on hematopoietic stem cell function and emergence of clonal hematopoiesis.$38,405
R01 · FY2021 · DK · contact PI
Impact of IL-1 signaling on hematopoietic stem cell function and emergence of clonal hematopoiesis.$378,798
R01 · FY2020 · DK · contact PI
Impact of IL-1 signaling on hematopoietic stem cell function and emergence of clonal hematopoiesis.$378,798
R01 · FY2019 · DK · contact PI
Pro-inflammatory cytokines in hematopoietic stem cell function$151,416
K01 · FY2018 · DK · contact PI
Pro-inflammatory cytokines in hematopoietic stem cell function$151,416
K01 · FY2017 · DK · contact PI
Pro-inflammatory cytokines in hematopoietic stem cell function$151,416
K01 · FY2016 · DK · contact PI
Pro-inflammatory cytokines in hematopoietic stem cell function$61,564
K01 · FY2015 · DK · contact PI
Pro-inflammatory cytokines in hematopoietic stem cell function$56,791
K01 · FY2015 · DK · contact PI
Pro-inflammatory cytokines in hematopoietic stem cell function$118,355
K01 · FY2014 · DK · contact PI
Regulation of normal and leukemic hematopoiesis by type I interferon$51,326
F32 · FY2011 · HL · contact PI